The role of retreatment in the management of recurrent/progressive brain metastases: a systematic review and evidence-based clinical practice guideline
Open Access
- 3 December 2009
- journal article
- review article
- Published by Springer Science and Business Media LLC in Journal of Neuro-Oncology
- Vol. 96 (1), 85-96
- https://doi.org/10.1007/s11060-009-0055-6
Abstract
Question What evidence is available regarding the use of whole brain radiation therapy (WBRT), stereotactic radiosurgery (SRS), surgical resection or chemotherapy for the treatment of recurrent/progressive brain metastases? Target population This recommendation applies to adults with recurrent/progressive brain metastases who have previously been treated with WBRT, surgical resection and/or radiosurgery. Recurrent/progressive brain metastases are defined as metastases that recur/progress anywhere in the brain (original and/or non-original sites) after initial therapy. Recommendation Level 3 Since there is insufficient evidence to make definitive treatment recommendations in patients with recurrent/progressive brain metastases, treatment should be individualized based on a patient’s functional status, extent of disease, volume/number of metastases, recurrence or progression at original versus non-original site, previous treatment and type of primary cancer, and enrollment in clinical trials is encouraged. In this context, the following can be recommended depending on a patient’s specific condition: no further treatment (supportive care), re-irradiation (either WBRT and/or SRS), surgical excision or, to a lesser extent, chemotherapy. Question If WBRT is used in the setting of recurrent/progressive brain metastases, what impact does tumor histopathology have on treatment outcomes? No studies were identified that met the eligibility criteria for this question.Keywords
This publication has 36 references indexed in Scilit:
- Methodology used to develop the AANS/CNS management of brain metastases evidence-based clinical practice parameter guidelinesJournal of Neuro-Oncology, 2009
- A phase II trial of vinorelbine and intensive temozolomide for patients with recurrent or progressive brain metastasesJournal of Neuro-Oncology, 2007
- Results of Surgical Resection for Progression of Brain Metastases Previously Treatedby Gamma Knife RadiosurgeryNeurosurgery, 2006
- Oral temozolomide in heavily pre-treated brain metastases from non-small cell lung cancer: Phase II studyLung Cancer, 2005
- Temozolomide plus thalidomide in patients with brain metastases from melanomaCancer, 2005
- Temozolomide (TMZ) combined with cisplatin (CDDP) in patients with brain metastases from solid tumors: a Hellenic Cooperative Oncology Group (HeCOG) Phase II studyJournal of Neuro-Oncology, 2005
- Repeated gamma knife radiosurgery for multiple metastatic brain tumoursActa Neurochirurgica, 2004
- Fotemustine given simultaneously with total brain irradiation in multiple brain metastases of malignant melanoma: report on a pilot studyMelanoma Research, 1996
- Reoperation for recurrent metastatic brain tumorsJournal of Neurosurgery, 1995
- Carboplatin as second line treatment for recurrent or progressive brain metastases from small cell lung cancerEuropean Journal Of Cancer, 1993